(Q39638600)

13 September 2017

title

Synthetic lethal hubs associated with vincristine resistant neuroblastoma (English)

1 reference

13 September 2017

11

1 reference

13 September 2017

9

Doron Lancet

1 reference

13 September 2017

10

Jindrich Cinatl

1 reference

13 September 2017

Raul Fechete

1

1 reference

13 September 2017

Susanne Barth

2

1 reference

13 September 2017

Tsviya Olender

3

1 reference

13 September 2017

Andreea Munteanu

4

1 reference

13 September 2017

Andreas Bernthaler

5

1 reference

13 September 2017

Aron Inger

6

1 reference

13 September 2017

Paul Perco

7

1 reference

13 September 2017

Arno Lukas

8

1 reference

13 September 2017

Bernd Mayer

12

1 reference

13 September 2017

publication date

28 October 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

7

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

200-214

1 reference

New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Analyses of novel prognostic factors in neuroblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

An anniversary for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Systemic chemotherapy for cancer: from weapon to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Induction of Akt activity by chemotherapy confers acquired resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Mechanisms of cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Anti-cancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

The natural history of vincristine-induced laryngeal paralysis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Examining the relationship between cancer invasion/metastasis and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Methodological approaches in application of synthetic lethality screening towards anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Genome-scale gene/reaction essentiality and synthetic lethality analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Global mapping of the yeast genetic interaction network

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Exploring genetic interactions and networks with yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Systematic mapping of genetic interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

The genetic landscape of a cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Human synthetic lethal inference as potential anti-cancer target gene detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Synthetic lethality--a new direction in cancer-drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Characterization of protein-interaction networks in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Scale-free networks in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Linking the ovarian cancer transcriptome and immunome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Multidrug efflux pumps: drug binding--gates or cavity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Is resistance useless? Multidrug resistance and collateral sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

MYCN oncoprotein targets and their therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Gene ontology: tool for the unification of biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Cytoskeletal mechanisms responsible for invasive migration of neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Tumour-cell invasion and migration: diversity and escape mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

The calcium channel blocker verapamil and cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Significant conservation of synthetic lethal genetic interaction networks between distantly related eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Distributed robustness in cellular networks: insights from synthetic evolved circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

A mutation in the gamma actin 1 (ACTG1) gene causes autosomal dominant hearing loss (DFNA20/26)

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

ArrayExpress--a public repository for microarray gene expression data at the EBI

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Human Gene-Centric Databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDE

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

The Mouse Genome Database (MGD): mouse biology and model systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00082E

21 January 2018

Identifiers

DOI

10.1039/C0MB00082E

1 reference

13 September 2017

1 reference